| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4532200
Max Phase: Preclinical
Molecular Formula: C23H24FN7O
Molecular Weight: 433.49
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: O=c1c2c(F)cccc2nc([C@@H]2CCCN2c2ncnc3[nH]cnc23)n1C1CCCCC1
Standard InChI: InChI=1S/C23H24FN7O/c24-15-8-4-9-16-18(15)23(32)31(14-6-2-1-3-7-14)21(29-16)17-10-5-11-30(17)22-19-20(26-12-25-19)27-13-28-22/h4,8-9,12-14,17H,1-3,5-7,10-11H2,(H,25,26,27,28)/t17-/m0/s1
Standard InChI Key: NWBAYSZRNWNCJO-KRWDZBQOSA-N
Associated Targets(Human)
SU-DHL-6 338 Activities
PI3-kinase p110-delta subunit 6699 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 433.49 | Molecular Weight (Monoisotopic): 433.2026 | AlogP: 4.05 | #Rotatable Bonds: 3 |
| Polar Surface Area: 92.59 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 9.83 | CX Basic pKa: 3.83 | CX LogP: 3.66 | CX LogD: 3.66 |
| Aromatic Rings: 4 | Heavy Atoms: 32 | QED Weighted: 0.52 | Np Likeness Score: -0.95 |
References
| 1. Ma X, Fang F, Tao Q, Shen L, Zhong G, Qiao T, Lv X, Li J.. (2019) Conformationally restricted quinazolone derivatives as PI3Kδ-selective inhibitors: the design, synthesis and biological evaluation., 10 (3): [PMID:30996859] [10.1039/C8MD00556G] |
Source
Source(1):